Table 1 Clinician vs. patient responses regarding rheumatic conditions and treatment
From: Survey self-report of rheumatoid arthritis and treatments versus specialist clinician confirmation
Clinician Yes N (%) | Patient Yes N (%) | Both Yes N | Clinician only, Yes N | Patient only, Yes N | Both No N | Agree (%) | PABAK | |
|---|---|---|---|---|---|---|---|---|
Arthritis Diagnosis | ||||||||
RA | 36 (100%) | 36 (100%) | 36 | 0 | 0 | 0 | 100 | 1 |
SLE | 0 | 2 (6%) | 0 | 0 | 2 | 34 | 94 | 0.89 |
Scleroderma | 1 (3%) | 1 (3%) | 1 | 0 | 0 | 35 | 100 | 1 |
Medication Prescribed | ||||||||
Methotrexate | 29 (81%) | 29 (81%) | 26 | 3 | 3 | 4 | 83 | 0.67 |
HCQ or Sulfasalazine | 22 (61%) | 21 (58%) | 16 | 6 | 5 | 9 | 69 | 0.39 |
Other conventional synthetic DMARD | 9 (25%) | 9 (25%) | 6 | 3 | 3 | 24 | 83 | 0.67 |
Biologic DMARD or JAK 2 inhibitor | 22 (61%) | 22 (61%) | 21 | 1 | 1 | 13 | 94 | 0.89 |